SPY366.02+3.96 1.09%
DIA298.44+1.82 0.61%
IXIC12,355.11+156.37 1.28%

Legend Biotech Q3 EPS $(0.25) Down From $(0.14) YoY, Sales $11.75M Down From $17.67M YoY

Legend Biotech (NASDAQ:LEGN) reported quarterly losses of $(0.25) per share. This is a 78.57 percent decrease over losses of $(0.14) per share from the same period last year. The company reported $11.75 million in sales

· 11/16/2020 07:07
Legend Biotech (NASDAQ:LEGN) reported quarterly losses of $(0.25) per share. This is a 78.57 percent decrease over losses of $(0.14) per share from the same period last year. The company reported $11.75 million in sales this quarter. This is a 33.54 percent decrease over sales of $17.67 million the same period last year.